Provided herein is a compound having the formula (I): ##STR00001## Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT.sub.1B and 5HT.sub.1D antagonists.
This application is a continuation of U.S. aplication Ser. No. 10/051,776 filed Jan. 16, 2002 now U.S. Pat. No. 6,812,225, now allowed, which claims priority to Swedish Application No. 0103650-8, filed Nov. 2, 2001 which claims the benefit of U.S. Provisional Application No. 60/262,107, filed Jan. 16, 2001, each of which is incorporated herein in its entirety by reference.
Priority Data
Nov 02, 2001 [SE] 0103650 Jan 15, 2002 [WO] PCT/SE02/00068
Provided herein is a compound having the formula (I): ##STR00001## Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT.sub.1B and 5HT.sub.1D antagonists.
